1016 related articles for article (PubMed ID: 19509380)
1. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
[TBL] [Abstract][Full Text] [Related]
2. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
Kamstrup PR; Nordestgaard BG
JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145
[TBL] [Abstract][Full Text] [Related]
3. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
[TBL] [Abstract][Full Text] [Related]
4. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
Kamstrup PR; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
Circulation; 2008 Jan; 117(2):176-84. PubMed ID: 18086931
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
[TBL] [Abstract][Full Text] [Related]
6. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
Frikke-Schmidt R; Nordestgaard BG; Stene MC; Sethi AA; Remaley AT; Schnohr P; Grande P; Tybjaerg-Hansen A
JAMA; 2008 Jun; 299(21):2524-32. PubMed ID: 18523221
[TBL] [Abstract][Full Text] [Related]
7. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
[TBL] [Abstract][Full Text] [Related]
8. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
[TBL] [Abstract][Full Text] [Related]
9. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
10. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
11. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study.
Kamstrup PR; Nordestgaard BG
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):220-7. PubMed ID: 24622370
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction.
Holmer SR; Hengstenberg C; Kraft HG; Mayer B; Pöll M; Kürzinger S; Fischer M; Löwel H; Klein G; Riegger GA; Schunkert H
Circulation; 2003 Feb; 107(5):696-701. PubMed ID: 12578871
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
[TBL] [Abstract][Full Text] [Related]
15. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
16. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
[TBL] [Abstract][Full Text] [Related]
17. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
Greve AM; Christoffersen M; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
JAMA Cardiol; 2021 Mar; 6(3):258-266. PubMed ID: 33237279
[TBL] [Abstract][Full Text] [Related]
18. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.
Pedersen SB; Langsted A; Nordestgaard BG
JAMA Intern Med; 2016 Dec; 176(12):1834-1842. PubMed ID: 27820614
[TBL] [Abstract][Full Text] [Related]
19. Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
Langsted A; Nordestgaard BG; Kamstrup PR
J Am Coll Cardiol; 2019 Jul; 74(1):54-66. PubMed ID: 31272552
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik J; Rifai N; Buring JE; Ridker PM
JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
